63. According to federal law, the prescribers DEA number must be included on a prescription for:

Answer: D

Explanation:

Prescribers must include their DEA number on a prescription for buprenorphine.

Buprenorphine is classified as a controlled substance under federal law, thus necessitating that prescribers include their DEA number on prescriptions for this medication to ensure proper regulation and tracking.

A) bupropion

Bupropion is not classified as a controlled substance; therefore, a DEA number is not required on prescriptions for this medication. It is primarily used as an antidepressant and smoking cessation aid, and its regulatory requirements differ from those of controlled substances.

B) buspirone

Buspirone is also not classified as a controlled substance, which means it does not require a DEA number when prescribed. It is used to treat anxiety disorders and has a different regulatory standing compared to medications like buprenorphine.

C) bumetanide

Bumetanide is a loop diuretic and is not classified as a controlled substance. Consequently, prescriptions for bumetanide do not require a DEA number, aligning it with other non-controlled medications.

D) buprenorphine

Buprenorphine is a Schedule III controlled substance, which mandates that prescribers include their DEA number on prescriptions. This requirement is in place to monitor and control the prescribing of medications that have potential for abuse.

Conclusion

Buprenorphine is the only option that requires a DEA number on prescriptions due to its classification as a controlled substance. The other options, bupropion, buspirone, and bumetanide, do not meet the criteria for controlled substances, and therefore, do not require a DEA number. This distinction is critical in ensuring compliance with federal regulations governing the prescription of controlled medications.